Corient Private Wealth LLC Reduces Stock Holdings in JPMorgan Chase & Co. (NYSE:JPM)

Corient Private Wealth LLC reduced its position in JPMorgan Chase & Co. (NYSE:JPM) by 4.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,526,963 shares of the financial services provider’s stock after selling 168,368 shares during the quarter. JPMorgan Chase & Co. makes up about 1.4% of Corient Private Wealth LLC’s holdings, making the stock its 11th largest position. Corient Private Wealth LLC’s holdings in JPMorgan Chase & Co. were worth $838,513,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. Midwest Capital Advisors LLC purchased a new stake in JPMorgan Chase & Co. in the 4th quarter worth about $43,000. Legacy Investment Solutions LLC purchased a new position in shares of JPMorgan Chase & Co. in the third quarter worth about $45,000. Collier Financial bought a new stake in shares of JPMorgan Chase & Co. in the fourth quarter valued at approximately $45,000. Lowe Wealth Advisors LLC lifted its stake in shares of JPMorgan Chase & Co. by 34.0% during the 4th quarter. Lowe Wealth Advisors LLC now owns 201 shares of the financial services provider’s stock valued at $48,000 after buying an additional 51 shares in the last quarter. Finally, Kieckhefer Group LLC bought a new position in JPMorgan Chase & Co. in the 4th quarter worth approximately $50,000. 71.55% of the stock is currently owned by institutional investors.

JPMorgan Chase & Co. Stock Up 1.0 %

Shares of NYSE:JPM opened at $241.49 on Monday. The firm has a market capitalization of $675.24 billion, a PE ratio of 12.23, a price-to-earnings-growth ratio of 2.83 and a beta of 1.10. The company has a debt-to-equity ratio of 1.24, a quick ratio of 0.89 and a current ratio of 0.88. JPMorgan Chase & Co. has a 52-week low of $179.20 and a 52-week high of $280.25. The firm has a fifty day moving average of $257.86 and a 200 day moving average of $239.50.

JPMorgan Chase & Co. (NYSE:JPM) last posted its quarterly earnings data on Wednesday, January 15th. The financial services provider reported $4.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.03 by $0.78. The firm had revenue of $42.77 billion during the quarter, compared to analysts’ expectations of $41.90 billion. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. The company’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same period in the prior year, the business earned $3.04 EPS. As a group, research analysts anticipate that JPMorgan Chase & Co. will post 18.1 EPS for the current fiscal year.

JPMorgan Chase & Co. Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 4th will be given a dividend of $1.40 per share. This is a boost from JPMorgan Chase & Co.’s previous quarterly dividend of $1.25. This represents a $5.60 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date of this dividend is Friday, April 4th. JPMorgan Chase & Co.’s dividend payout ratio (DPR) is presently 28.37%.

Insiders Place Their Bets

In other JPMorgan Chase & Co. news, General Counsel Stacey Friedman sold 3,303 shares of the company’s stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $253.94, for a total transaction of $838,763.82. Following the completion of the sale, the general counsel now directly owns 47,620 shares in the company, valued at $12,092,622.80. This represents a 6.49 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Troy L. Rohrbaugh sold 37,500 shares of JPMorgan Chase & Co. stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $269.84, for a total value of $10,119,000.00. Following the completion of the transaction, the chief executive officer now owns 158,381 shares in the company, valued at approximately $42,737,529.04. This represents a 19.14 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 46,326 shares of company stock valued at $12,448,445. 0.79% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on JPM. Baird R W raised shares of JPMorgan Chase & Co. from a “strong sell” rating to a “hold” rating in a report on Friday, March 7th. Truist Financial increased their price objective on JPMorgan Chase & Co. from $260.00 to $268.00 and gave the stock a “hold” rating in a report on Thursday, January 16th. UBS Group lifted their target price on JPMorgan Chase & Co. from $276.00 to $287.00 and gave the company a “buy” rating in a report on Thursday, January 16th. Robert W. Baird raised shares of JPMorgan Chase & Co. from an “underperform” rating to a “neutral” rating and increased their price target for the stock from $215.00 to $220.00 in a report on Friday, March 7th. Finally, Piper Sandler raised their price objective on shares of JPMorgan Chase & Co. from $240.00 to $275.00 and gave the company an “overweight” rating in a research report on Tuesday, December 3rd. Ten research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $252.89.

JPMorgan Chase & Co. Profile

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.